Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariona Pascal

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|October 12, 2017
Mechanisms, Cofactors, and Augmenting Factors Involved in AnaphylaxisRosa Muñoz-Cano, Mariona Pascal, Giovanna Araujo, et al.
Journal of Clinical Medicine|November 26, 2022
Skin Manifestations in Patients with Selective Immunoglobulin E DeficiencyCésar Picado, Adriana P García-Herrera, José Hernández-Rodríguez, et al.
The Journal of Allergy and Clinical Immunology|March 17, 2015
Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergyLuis Diego Archila, David Jeong, Mariona Pascal, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2021
Epitope Mapping of Allergenic Lipid Transfer ProteinsClara San Bartolomé, Carmen Oeo-Santos, Pablo San Segundo-Acosta, et al.
Frontiers in Immunology|November 12, 2020
Manufacturing and Management of CAR T-Cell Therapy in "COVID-19's Time": Central Versus Point of Care ProposalsIñaki Ortiz de Landazuri, Natalia Egri, Guillermo Muñoz-Sánchez, et al.
Allergy|June 15, 2020
Phenotyping peach-allergic patients sensitized to lipid transfer protein and analysing severity biomarkersGador Bogas, Rosa Muñoz-Cano, Cristobalina Mayorga, et al.
Cancers|September 28, 2021
CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?Ariadna Bartoló-Ibars, Mireia Uribe-Herranz, Guillermo Muñoz-Sánchez, et al.
British Journal of Clinical Pharmacology|January 10, 2018
Fixed dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysisCarla Bastida, Virginia Ruiz-Esquide, Mariona Pascal, et al.
International Review of Cell and Molecular Biology|July 7, 2022
What will (and should) be improved in CAR immunotherapy?Europa Azucena González-Navarro, Marta Español, Natalia Egri, et al.
Frontiers in Allergy|June 30, 2022
Low Levels Matter: Clinical Relevance of Low Pru p 3 sIgE in Patients With Peach AllergySara Balsells-Vives, Clara San Bartolomé, Rocío Casas-Saucedo, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|October 12, 2017
Mechanisms, Cofactors, and Augmenting Factors Involved in AnaphylaxisRosa Muñoz-Cano, Mariona Pascal, Giovanna Araujo, et al.
Journal of Clinical Medicine|November 26, 2022
Skin Manifestations in Patients with Selective Immunoglobulin E DeficiencyCésar Picado, Adriana P García-Herrera, José Hernández-Rodríguez, et al.
The Journal of Allergy and Clinical Immunology|March 17, 2015
Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergyLuis Diego Archila, David Jeong, Mariona Pascal, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2021
Epitope Mapping of Allergenic Lipid Transfer ProteinsClara San Bartolomé, Carmen Oeo-Santos, Pablo San Segundo-Acosta, et al.
Frontiers in Immunology|November 12, 2020
Manufacturing and Management of CAR T-Cell Therapy in "COVID-19's Time": Central Versus Point of Care ProposalsIñaki Ortiz de Landazuri, Natalia Egri, Guillermo Muñoz-Sánchez, et al.
Allergy|June 15, 2020
Phenotyping peach-allergic patients sensitized to lipid transfer protein and analysing severity biomarkersGador Bogas, Rosa Muñoz-Cano, Cristobalina Mayorga, et al.
Cancers|September 28, 2021
CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?Ariadna Bartoló-Ibars, Mireia Uribe-Herranz, Guillermo Muñoz-Sánchez, et al.
British Journal of Clinical Pharmacology|January 10, 2018
Fixed dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysisCarla Bastida, Virginia Ruiz-Esquide, Mariona Pascal, et al.
International Review of Cell and Molecular Biology|July 7, 2022
What will (and should) be improved in CAR immunotherapy?Europa Azucena González-Navarro, Marta Español, Natalia Egri, et al.
Frontiers in Allergy|June 30, 2022
Low Levels Matter: Clinical Relevance of Low Pru p 3 sIgE in Patients With Peach AllergySara Balsells-Vives, Clara San Bartolomé, Rocío Casas-Saucedo, et al.
Pageof 8